Ethiodized oil
- Generic Name
- Ethiodized oil
- Brand Names
- Lipiodol, Lipiodol Ultra Fluide
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 8008-53-5
- Unique Ingredient Identifier
- KZW0R0686Q
- Background
Ethiodized oil is used by injection as a radio-opaque contrast agent. The composition of the oil is comprised of iodine combined with ethyl esters of fatty acids of poppyseed oil. And although these esters are primarily as ethyl monoiodostearate and ethyl diiodostearate, the actual, specific structure is unknown.
- Indication
For use as a radio-opaque medium for hysterosalpingography and lymphography, and as an antineoplastic agent when part of the iodine is 131-I. It is also used in follow-up imaging for chemoembolization.
- Associated Conditions
- Hepatocellular Carcinoma
- Associated Therapies
- -
Injection of Cyanoacrylate+Lipiodol vs Cyanoacrylate+Lauromacrogol in Gastric Varices
- Conditions
- Interventions
- First Posted Date
- 2013-08-14
- Last Posted Date
- 2016-01-05
- Lead Sponsor
- Shanghai Zhongshan Hospital
- Target Recruit Count
- 96
- Registration Number
- NCT01923064
- Locations
- 🇨🇳
Zhongshan Hospital, Shanghai, Shanghai, China
Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer
- First Posted Date
- 2013-06-13
- Last Posted Date
- 2020-04-15
- Lead Sponsor
- Yale University
- Target Recruit Count
- 39
- Registration Number
- NCT01877187
- Locations
- 🇺🇸
The Johns Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸Smilow Cancer Center, New Haven, Connecticut, United States
Arsenic Trioxide TACE and Intravenous Administration in Unresectable Hepatocellular Carcinoma
- First Posted Date
- 2013-05-24
- Last Posted Date
- 2013-06-05
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 258
- Registration Number
- NCT01861912
Iodine I 131 Ethiodized Oil in Preventing Recurrent Cancer in Patients Who Have Undergone Treatment for Liver Cancer
- Conditions
- Interventions
- First Posted Date
- 2009-03-27
- Last Posted Date
- 2011-08-16
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 120
- Registration Number
- NCT00870558
- Locations
- 🇫🇷
Hopital Edouard Herriot - Lyon, Lyon, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.